OBJECTIVE: Biomarkers of low-grade inflammation and endothelial dysfunction are associated with cardiovascular disease. Arterial stiffening may be a mechanism through which low-grade inflammation and (or) endothelial dysfunction lead to cardiovascular disease. Therefore, we investigated whether low-grade inflammation and endothelial dysfunction were associated with greater carotid stiffness in a population-based cohort of elderly individuals. METHODS: We determined biomarkers of low-grade inflammation (C-reactive protein, serum amyloid A, interleukin 6, interleukin 8, tumour necrosis factor α and soluble intercellular adhesion molecule 1), and of endothelial dysfunction (von Willebrand factor, soluble vascular cell adhesion molecule 1, soluble endothelial selectin, soluble thrombomodulin, soluble intercellular adhesion molecule 1 and flow-mediated dilation), and combined these into mean z-scores (n = 572; women = 286; age 67.5 ± 6.6 years). Additionally, we determined by ultrasonography carotid diameter, distension, pulse pressure and intima-media thickness. Carotid stiffness indices were determined by calculation of the distensibility and compliance coefficient, Young's elastic modulus and β stiffness index. RESULTS: The study population was characterized by a high prevalence of cardiovascular disease (46%), hypertension (66%) and the use of lipid-lowering (16%) and antihypertensive (34%) medication. After adjustment for the above in addition to sex, age, glucose tolerance status and current smoking, the low-grade inflammation z-score was positively associated with Young's elastic modulus [β (95% confidence interval) 0.080 (0.021-0.139), P = 0.008]. This association was primarily driven through greater diameter. After adjustment for the variables above, the endothelial dysfunction z-score was not associated with carotid stiffness. CONCLUSION: These data suggest that low-grade inflammation, in the elderly, plays an important role in carotid artery remodelling and stiffening.
OBJECTIVE: Biomarkers of low-grade inflammation and endothelial dysfunction are associated with cardiovascular disease. Arterial stiffening may be a mechanism through which low-grade inflammation and (or) endothelial dysfunction lead to cardiovascular disease. Therefore, we investigated whether low-grade inflammation and endothelial dysfunction were associated with greater carotid stiffness in a population-based cohort of elderly individuals. METHODS: We determined biomarkers of low-grade inflammation (C-reactive protein, serum amyloid A, interleukin 6, interleukin 8, tumour necrosis factor α and soluble intercellular adhesion molecule 1), and of endothelial dysfunction (von Willebrand factor, soluble vascular cell adhesion molecule 1, soluble endothelial selectin, soluble thrombomodulin, soluble intercellular adhesion molecule 1 and flow-mediated dilation), and combined these into mean z-scores (n = 572; women = 286; age 67.5 ± 6.6 years). Additionally, we determined by ultrasonography carotid diameter, distension, pulse pressure and intima-media thickness. Carotid stiffness indices were determined by calculation of the distensibility and compliance coefficient, Young's elastic modulus and β stiffness index. RESULTS: The study population was characterized by a high prevalence of cardiovascular disease (46%), hypertension (66%) and the use of lipid-lowering (16%) and antihypertensive (34%) medication. After adjustment for the above in addition to sex, age, glucose tolerance status and current smoking, the low-grade inflammation z-score was positively associated with Young's elastic modulus [β (95% confidence interval) 0.080 (0.021-0.139), P = 0.008]. This association was primarily driven through greater diameter. After adjustment for the variables above, the endothelial dysfunction z-score was not associated with carotid stiffness. CONCLUSION: These data suggest that low-grade inflammation, in the elderly, plays an important role in carotid artery remodelling and stiffening.
Authors: Guanghong Jia; Javad Habibi; Annayya R Aroor; Michael A Hill; Yan Yang; Adam Whaley-Connell; Frederic Jaisser; James R Sowers Journal: Hypertension Date: 2018-09 Impact factor: 10.190
Authors: L Joly; D Mandry; A Verger; C Labat; G Watfa; V Roux; G Karcher; P-Y Marie; A Benetos Journal: J Nutr Health Aging Date: 2016-03 Impact factor: 4.075
Authors: Luenda E Charles; Desta Fekedulegn; Cecil M Burchfiel; Kaori Fujishiro; Paul Landsbergis; Ana V Diez Roux; Leslie Macdonald; Capri G Foy; Michael E Andrew; Karen H Stukovsky; Sherry Baron Journal: Occup Environ Med Date: 2012-07-05 Impact factor: 4.402
Authors: Sae Young Jae; Eun Sun Yoon; Soo Jin Jung; Sol Gi Jung; Soo Hyun Park; Byung Sung Kim; Kevin S Heffernan; Bo Fernhall Journal: Eur J Appl Physiol Date: 2013-04-25 Impact factor: 3.078
Authors: Bas C T van Bussel; Isabel Ferreira; Marjo P H van de Waarenburg; Marleen M J van Greevenbroek; Carla J H van der Kallen; Ronald M A Henry; Edith J M Feskens; Coen D A Stehouwer; Casper G Schalkwijk Journal: PLoS One Date: 2013-03-05 Impact factor: 3.240
Authors: Brent T Mausbach; Rosa Romero-Moreno; Taylor Bos; Roland von Känel; Michael G Ziegler; Matthew A Allison; Paul J Mills; Joel E Dimsdale; Sonia Ancoli-Israel; Andrés Losada; María Márquez-González; Thomas L Patterson; Igor Grant Journal: Psychosom Med Date: 2017-09 Impact factor: 4.312
Authors: B C T van Bussel; R M A Henry; C G Schalkwijk; J M Dekker; G Nijpels; E J M Feskens; C D A Stehouwer Journal: Eur J Nutr Date: 2017-03-27 Impact factor: 5.614